Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
Abstract
We report six demented individuals with pathologically verified diffuse Lewy body disease (DLBD) studied with fluoro-deoxyglucose positron emission tomography (FDG-PET). Three subjects had pure DLBD and three subjects had combined DLBD and Alzheimer's disease (DLBD-AD) pathology. FDG-PET revealed evidence of diffuse cerebral hypometabolism in both pure DLBD and DLBD-AD with marked declines in association cortices with relative sparing of subcortical structures and primary somatomotor cortex, a pattern reported previously in AD. Unlike AD, however, these subjects also had hypometabolism in the occipital association cortex and primary visual cortex. These findings indicate the presence of diffuse cortical abnormalities in DLBD and suggest that FDG-PET may be useful in discriminating DLBD from AD antemortem.
NEUROLOGY 1996;47: 462-466
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol 1993;60:456-463.
2.
Perry PH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. J Neurol Sci 1990;95:119-139.
3.
Byrne J, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52:709-717.
4.
Gibb RG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1985;110:1131-1153.
5.
Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-191.
6.
Sima AAF, Clark AW, Sternberger NA, Sternberger LA. Lewy body dementia without Alzheimer changes. Can J Neurol Sci 1986;13:490-497.
7.
Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990;40:1523-1528.
8.
Lennox G, Lowe J, Landon M, Byrne E, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-1247.
9.
Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-654.
10.
McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
11.
McKeith IG, Fairbairn AF, Bothwell RA, et al. Evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.
12.
Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomical standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537.
13.
Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A new diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of [sup 18 F]FDG. J Nucl Med 1995;36:1238-1248.
14.
Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer's disease: a reference region for functional brain image analysis. J Comput Assist Tomogr 1995;19:541-547.
15.
Hutchins GD, Holden JE, Koeppe RA, Halama JR, Gatley SJ, Nickles RJ. Alternative approach to single scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia. J Cereb Blood Flow Metab 1984;4:35-40.
16.
Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme, 1988.
17.
Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet 1994;344:895.
18.
Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss WD. Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1990;1:156-164.
19.
Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-887.
20.
Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989;52:67-71.
21.
Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
22.
Goto I, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimaya A. Positron emission tomography studies in dementia. J Neurol Sci 1993;114:1-6.
23.
Hof PR, Bouras C, Constantinidis J, Morrison JH. Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropathol Exp Neurol 1990;49:168-184.
24.
Hof PR, Bouras C, Constantinidis J, Morrison JH. Balint's syndrome in Alzheimer's disease: specific disruption of the occipitoparietal visual pathway. Brain Res 1989;493:368-375.
25.
Levine DN, Lee JM, Fisher CM. The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 1993;43:305-313.
26.
Berthier ML, Leiguarda R, Starkstein SE, Sevlever G, Taratuto AL. Alzheimer's disease in a patient with posterior cortical atrophy. J Neurol Neurosurg Psychiatry 1991;54:1110-1111.
27.
Kiyosawa M, Bosley TM, Chawluk J, et al. Alzheimer's disease with prominent visual symptoms. Ophthalmology 1989;96:1077-1086.
28.
Pietrini P, Freo U, Grady CL, et al. A longitudinal positron emission tomography study of cerebral glucose metabolism in patients with Alzheimer's disease and prominent visual impairment. Adv Biosciences 1993;87:69-71.
29.
Perry EK, McKeith I, Thompson P, et al. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann NY Acad Sci 1991;640:197-202.
30.
Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994;35:81-88.
31.
Dickson DW, Schmidt ML-Y, Lee VM-Y, Zhao ML, Yen S-H, Trojanowski JQ. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol (Berl) 1994;87:269-276.
32.
Harrington CR, Perry RH, Perry EK, et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 1994;5:215-228.
33.
Dickson DW, Crystal H, Mattiace LA, et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (Berl) 1989;78:572-584.
34.
Perry EK, Marshall E, Thompson P, et al. Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. J Neural Transm Park Dis Dement Sect 1993;6:167-177.
35.
Smith MC, Mallory M, Hansen LA, Ge N, Masliah E. Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. Neuroreport 1995;6:673-676.
Information & Authors
Information
Published In
Copyright
Copyright 1996 by Advanstar Communications Inc.
Publication History
Published online: August 1, 1996
Published in print: August 1996
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Differences in Retinal and Choroidal Microvasculature and Structure in Dementia With Lewy Bodies Compared With Normal Cognition, Journal of VitreoRetinal Diseases, (2023).https://doi.org/10.1177/24741264231206607
- Regional Metabolic Changes Influencing Three-Dimensional Perception in Parkinson’s Disease, Journal of Clinical Neurology, 18, 4, (447), (2022).https://doi.org/10.3988/jcn.2022.18.4.447
- Altered resting state brain metabolic connectivity in dementia with Lewy bodies, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.847935
- Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on 18 F-FDG PET Patterns in Clinical Alzheimer Disease , Journal of Nuclear Medicine, 64, 2, (274-280), (2022).https://doi.org/10.2967/jnumed.122.264213
- Visual signs and symptoms of dementia with Lewy bodies, Clinical and Experimental Optometry, 95, 6, (621-630), (2021).https://doi.org/10.1111/j.1444-0938.2012.00770.x
- FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD, NeuroImage: Clinical, 31, (102754), (2021).https://doi.org/10.1016/j.nicl.2021.102754
- The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia, Neurobiology of Aging, 99, (11-18), (2021).https://doi.org/10.1016/j.neurobiolaging.2020.12.009
- Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism, Neurotherapeutics, 18, 2, (753-771), (2021).https://doi.org/10.1007/s13311-020-00994-4
- Neurological Applications of Radiopharmaceuticals, Handbook of Radiopharmaceuticals, (571-606), (2021).https://doi.org/10.1002/9781119500575.ch19
- Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study, NeuroImage: Clinical, 28, (102504), (2020).https://doi.org/10.1016/j.nicl.2020.102504
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.